Same Indication

Lutetium Oxodotreotide Lu-177 vs Osimertinib

Lutetium Oxodotreotide Lu-177 vs Osimertinib: Overview

This comparison examines the pharmacological differences between Lutetium Oxodotreotide Lu-177 and Osimertinib.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Osimertinib β€” 48 hours.

Chemical Properties

Molecular Formula: Osimertinib β€” C28H33N7O2.

Molecular Weight: Osimertinib β€” 499.6050 g/mol.

Type: Lutetium Oxodotreotide Lu-177 β€” Protein; Osimertinib β€” Small molecule.